ロード中...
Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
Glucocorticoids (GCs) such as dexamethasone (DEX) are administered as cancer co-treatment for palliative purposes due to their pro-apoptotic effects in lymphoid cancer and limited side effects associated with cancer growth and chemotherapy. However, there is emerging evidence that GCs induce therapy...
保存先:
| 出版年: | Int J Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6255064/ https://ncbi.nlm.nih.gov/pubmed/30387838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4616 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|